© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 7.96% of GANX shares are held by financial institutions. XTX TOPCO LTD is the top corporate investor, holding 0 shares valued at -. A 0% stake in Gain Therapeutics, Inc. is owned by the company. ROYAL BANK OF CANADA owns 248.5K shares valued at $937.00K, which translates its holding of 1.53% of the stake in the company.
Among the GANX insiders holding of 5.09% of the stake in company, , , holds the largest shares of -. , , is the second largest GANX insider with ownership of - shares. , , stands third with possession of - shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GANX shares is 24, representing 7.96% of the company's common stock.
XTX TOPCO LTD, in the last quarter, reduced its stake in GANX by -100% restricting it's holding to 0 shares of worth nearly -. CITADEL ADVISORS LLC also lessened -64.29% of the GANX shares from its portfolio, reducing its holding to 2.5 thousand shares of worth $9.43K. GROUP ONE TRADING, L.P. also shunned GANX shares holding by -49.17% last quarter which brought its holding to 2 thousand shares worth $7.54K.
As per its latest 13F filing, ROYAL BANK OF CANADA increased its stake in GANX by 24.1% in the last quarter. The institutional holder raised its holding to 248.5 thousand shares having worth more than $937.00K. GEODE CAPITAL MANAGEMENT, LLC also added 16.91% more shares of GANX to its portfolio, raising its holding to 177.09 thousand shares of worth $667.73K. VANGUARD GROUP INC also increased its GANX shares holding by 35.05% which brought its holding to 119.36 thousand shares worth $450.00K.
The insider with the most stakes in GANX is N/A , N/A at the company. Additionally, GANX stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own 5.09% percent of Gain Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which GANX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ALDER MATTHIAS.
There have been 2 transaction(s) during the past 6-months in which Gain Therapeutics, Inc. insiders have bought stock, totalling 64400 shares
Around 64.4K Gain Therapeutics, Inc. shares are held by insiders, which represents about 5.09% of GANX stock.
GANX N/A, N/A holds the largest portfolio of the company's shares. GANX shares owned by N/A total nearly -.
XTX TOPCO LTD is the largest institutional owner in GANX which holds 0 shares worth - or 0% of the total GANX shares outstanding followed by ROYAL BANK OF CANADA with ownership of 248.5 thousand shares representing 1.53% of the GANX ownership. GEODE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 177.09 thousand shares or 1.09% of the ownership worth more than $667.73K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GANX is concerned, it is a stock which is optionable.
Number of GANX shares short is 658.34K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 26.53M shares of GANX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GANX has 24.23M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GANX is 1.65.